BR0307565A - Derivados da piridazina, sua utilização como medicamentos, composições farmacêuticas e seu processo de preparação - Google Patents
Derivados da piridazina, sua utilização como medicamentos, composições farmacêuticas e seu processo de preparaçãoInfo
- Publication number
- BR0307565A BR0307565A BR0307565-6A BR0307565A BR0307565A BR 0307565 A BR0307565 A BR 0307565A BR 0307565 A BR0307565 A BR 0307565A BR 0307565 A BR0307565 A BR 0307565A
- Authority
- BR
- Brazil
- Prior art keywords
- medicines
- pharmaceutical compositions
- preparation process
- pyridazine derivatives
- pyridazine
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000004892 pyridazines Chemical class 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0201632A FR2835835B1 (fr) | 2002-02-11 | 2002-02-11 | Nouveaux derives de la pyridazine, leur utilisation comme medicaments, compositions pharmaceutiques et leur procede de preparation |
| PCT/FR2003/000381 WO2003068140A2 (fr) | 2002-02-11 | 2003-02-07 | Derives de la pyridazine, leur utilisation comme medicaments, et leur procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0307565A true BR0307565A (pt) | 2004-12-21 |
Family
ID=27620073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0307565-6A BR0307565A (pt) | 2002-02-11 | 2003-02-07 | Derivados da piridazina, sua utilização como medicamentos, composições farmacêuticas e seu processo de preparação |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7223758B2 (OSRAM) |
| EP (1) | EP1476434B1 (OSRAM) |
| JP (1) | JP4447324B2 (OSRAM) |
| AT (1) | ATE329907T1 (OSRAM) |
| AU (1) | AU2003222363A1 (OSRAM) |
| BR (1) | BR0307565A (OSRAM) |
| CA (1) | CA2475439A1 (OSRAM) |
| CY (1) | CY1107483T1 (OSRAM) |
| DE (1) | DE60306122T2 (OSRAM) |
| DK (1) | DK1476434T3 (OSRAM) |
| ES (1) | ES2266806T3 (OSRAM) |
| FR (1) | FR2835835B1 (OSRAM) |
| MX (1) | MXPA04007186A (OSRAM) |
| PT (1) | PT1476434E (OSRAM) |
| WO (1) | WO2003068140A2 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2839309B1 (fr) * | 2002-05-03 | 2004-07-23 | Aventis Pharma Sa | Nouveaux derives de l'acide hexahydro-pyridazine-3- carboxylique, chimiotheques les contenant, leur utilisation comme medicaments, compositions pharmaceutiques les contenant et leurs procedes de preparation |
| JP2008531503A (ja) * | 2005-02-23 | 2008-08-14 | スミスクライン ビーチャム コーポレーション | グルココルチコイド受容体のモジュレーターとしてのナフタレン誘導体 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ112694A3 (en) * | 1991-11-08 | 1994-12-15 | Sankyo Co | Derivatives of piperizinecarboxylic acids and process for preparing thereof |
-
2002
- 2002-02-11 FR FR0201632A patent/FR2835835B1/fr not_active Expired - Fee Related
-
2003
- 2003-02-07 DE DE60306122T patent/DE60306122T2/de not_active Expired - Lifetime
- 2003-02-07 AU AU2003222363A patent/AU2003222363A1/en not_active Abandoned
- 2003-02-07 MX MXPA04007186A patent/MXPA04007186A/es unknown
- 2003-02-07 PT PT03717380T patent/PT1476434E/pt unknown
- 2003-02-07 BR BR0307565-6A patent/BR0307565A/pt not_active IP Right Cessation
- 2003-02-07 EP EP03717380A patent/EP1476434B1/fr not_active Expired - Lifetime
- 2003-02-07 AT AT03717380T patent/ATE329907T1/de active
- 2003-02-07 WO PCT/FR2003/000381 patent/WO2003068140A2/fr not_active Ceased
- 2003-02-07 JP JP2003567325A patent/JP4447324B2/ja not_active Expired - Fee Related
- 2003-02-07 CA CA002475439A patent/CA2475439A1/fr not_active Abandoned
- 2003-02-07 ES ES03717380T patent/ES2266806T3/es not_active Expired - Lifetime
- 2003-02-07 DK DK03717380T patent/DK1476434T3/da active
-
2004
- 2004-08-11 US US10/916,175 patent/US7223758B2/en not_active Expired - Lifetime
-
2006
- 2006-09-07 CY CY20061101281T patent/CY1107483T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2475439A1 (fr) | 2003-08-21 |
| ES2266806T3 (es) | 2007-03-01 |
| EP1476434B1 (fr) | 2006-06-14 |
| MXPA04007186A (es) | 2004-10-29 |
| PT1476434E (pt) | 2006-10-31 |
| DE60306122D1 (de) | 2006-07-27 |
| DK1476434T3 (da) | 2006-10-16 |
| US20050165017A1 (en) | 2005-07-28 |
| AU2003222363A1 (en) | 2003-09-04 |
| WO2003068140A3 (fr) | 2004-04-08 |
| CY1107483T1 (el) | 2013-03-13 |
| JP4447324B2 (ja) | 2010-04-07 |
| FR2835835A1 (fr) | 2003-08-15 |
| WO2003068140A2 (fr) | 2003-08-21 |
| DE60306122T2 (de) | 2007-06-06 |
| ATE329907T1 (de) | 2006-07-15 |
| EP1476434A2 (fr) | 2004-11-17 |
| JP2005525334A (ja) | 2005-08-25 |
| US7223758B2 (en) | 2007-05-29 |
| FR2835835B1 (fr) | 2004-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR122019010008B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
| BR0312513A (pt) | Derivados de glicosìdeo de tiofeno, processos para a produção dos mesmos, medicamentos que contêm esses compostos e uso dos mesmos | |
| BR0210711A (pt) | Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto | |
| DE60140708D1 (de) | Prolinderivative und deren Verwendung als Medikamente | |
| BRPI0409977A (pt) | derivados de aminopropanol como moduladores de receptores esfingosina-1-fosfato | |
| BR0315158A (pt) | Compostos de pirazol para o tratamento de distúrbios neurodegenarativos | |
| BR0308967A (pt) | Derivados de quinolina e isoquinolina, um processo para a sua preparação e sua aplicação como inibidores de inflamação | |
| BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
| NO20070339L (no) | 1-aza-bicyklo[3 3.1]nonaner | |
| BRPI0412851A (pt) | benzamidazóis de n-metila-substituìdos | |
| EA201000643A1 (ru) | Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе | |
| AR022469A1 (es) | Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias | |
| BR0214243A (pt) | Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida | |
| GB0313612D0 (en) | Organic compounds | |
| BRPI0516842A (pt) | compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por lxr alfa e/ou lxr beta agonistas e uso desses compostos | |
| BRPI0406717A (pt) | Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção | |
| ATE372995T1 (de) | Benzo(b)(1,4)dioxepinderivate | |
| BRPI0511874A (pt) | derivados da pirrolopiridina | |
| PT1259498E (pt) | Derivados do 8,8a-di-hidroindeno[1,2-d]tiazole substituidos na posicao 8a, processo para a sua preparacao e sua utilizacao como medicamentos, p. ex. como anorecticos | |
| BRPI0607583A2 (pt) | derivados de piridin-2-carboxamida como antagonistas mglur5, método para sua preparação, medicamento contendo os mesmos, bem como uso relacionado aos referidos compostos | |
| BR0215277A (pt) | Dicetopiperazinas substituìdas como antagonistas da oxitocina | |
| BR0314195A (pt) | Derivados de piridina substituìda como agentes antitumorais | |
| BRPI0519620A2 (pt) | compostos, processo para a sua manufatura, composiÇÕes farmacÊuticas que os compreendem, mÉtodo para o tratamento terapÊutico e/ou profilÁtico de enfermidades que sço moduladas por agonistas alfa-lxr e/ou beta-lxr e utilizaÇço desses compostos | |
| BR0013313A (pt) | Derivados substituìdos de pirrolidino-2,3,4- triona-3-oxina eficazes como antagonistas de receptores de nmda | |
| MXPA05012679A (es) | Nuevos derivados de imidazoles, su preparacion y su uso como medicamento. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 5A., 6A., E 7A. ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010. |